Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sandy Pelletier

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Cancer Immunology, Immunotherapy : CII|December 5, 2008
TGF-alpha as a candidate tumor antigen for renal cell carcinomasSandy Pelletier, Simon Tanguay, Stephen Lee, et al.
Journal of Virology|April 12, 2013
Sustained hyperresponsiveness of dendritic cells is associated with spontaneous resolution of acute hepatitis CSandy Pelletier, Nathalie Bédard, Elias Said, et al.
Immunity, Inflammation and Disease|September 14, 2016
IFN-λ3 polymorphism indirectly influences NK cell phenotype and function during acute HCV infectionMarion Depla, Sandy Pelletier, Nathalie Bédard, et al.
Journal of Hepatology|August 7, 2010
Increased degranulation of natural killer cells during acute HCV correlates with the magnitude of virus-specific T cell responsesSandy Pelletier, Christian Drouin, Nathalie Bédard, et al.
Plos One|April 25, 2012
Altered thymic function during interferon therapy in HCV-infected patientsStephanie Beq, Sandra Rozlan, Sandy Pelletier, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 26, 2009
Human activated T lymphocytes modulate IDO expression in tumors through Th1/Th2 balanceJessica Godin-Ethier, Sandy Pelletier, Laïla-Aïcha Hanafi, et al.
Cell Reports|March 2, 2025
The NF1 tumor suppressor regulates PD-L1 and immune evasion in melanomaDiana Berry, Dan Moldoveanu, Shivshankari Rajkumar, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Cancer Immunology, Immunotherapy : CII|December 5, 2008
TGF-alpha as a candidate tumor antigen for renal cell carcinomasSandy Pelletier, Simon Tanguay, Stephen Lee, et al.
Journal of Virology|April 12, 2013
Sustained hyperresponsiveness of dendritic cells is associated with spontaneous resolution of acute hepatitis CSandy Pelletier, Nathalie Bédard, Elias Said, et al.
Immunity, Inflammation and Disease|September 14, 2016
IFN-λ3 polymorphism indirectly influences NK cell phenotype and function during acute HCV infectionMarion Depla, Sandy Pelletier, Nathalie Bédard, et al.
Journal of Hepatology|August 7, 2010
Increased degranulation of natural killer cells during acute HCV correlates with the magnitude of virus-specific T cell responsesSandy Pelletier, Christian Drouin, Nathalie Bédard, et al.
Plos One|April 25, 2012
Altered thymic function during interferon therapy in HCV-infected patientsStephanie Beq, Sandra Rozlan, Sandy Pelletier, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 26, 2009
Human activated T lymphocytes modulate IDO expression in tumors through Th1/Th2 balanceJessica Godin-Ethier, Sandy Pelletier, Laïla-Aïcha Hanafi, et al.
Cell Reports|March 2, 2025
The NF1 tumor suppressor regulates PD-L1 and immune evasion in melanomaDiana Berry, Dan Moldoveanu, Shivshankari Rajkumar, et al.
Pageof 1